The purpose of this study is the evaluation of remission rate between escitalopram 20 mg and
30 mg in patients with major depressive disorder.
We will connect you to the doctor responsible for this trial and help you get more information.
Locations near you
Unfortunately, there are no recruiting locations near you. Please check the list with all locations below.
Full eligibility criteria for NCT01594866
Ages eligible for Study
18 Years to 65 Years
Genders eligible for Study
Accepts Healthy Volunteers
Age: 18 ~ 65
Patient with major depressive disorder according to DSM-IV criteria
Patient have signed on the informed consent, and well understood the objective and procedure of this study.
MADRS total score ≥ 18
Competent patient who is manage to answer the questionnaires.
In case of female at child-bearing age, consent to use appropriate contraceptive methods(oral pill, contraceptive injection, intrauterine device, double barrier method and contraceptive patch) during entire duration of this study.
In previous depressive episodes, no efficacy although more than one antidepressant treatment
Allergy or hypersensitivity to escitalopram
Diagnosed to schizophrenia or bipolar disorder or schizoaffective disorder (DSM-IV)
MADRS 10 score ≥ 5, or patient who is supposed to be impossible to participate to this study due to clinical risk of suicide or aggressive behavior based on clinician's opinion
Pregnant or breast-feeding female patient
Significant biochemical or hematological abnormality or abnormal finding of urinalysis, based on clinician's opinion
Significant severe medical condition
Patients who take antipsychotics or mood stabilizer or other psychiatric drugs excluding benzodiazepines or beta blockers or hypnotics
History of participating to other investigational drug trial within 1month prior to screening
Investigator or employee at clinical trial center, personnel related to investigator or trial center on this or other study, or family of employee or investigator
All locations for NCT01594866
Korea, Republic of (1)
Seoul National University
Seoul, Korea, Republic of
View full eligibility
Tris trial is registered with FDA with number: NCT01594866. The sponsor of the trial is Seoul National University Hospital and it is looking for 60 volunteers for the current phase.
Official trial title: A Double-blinded 6-week Prospective Study to Evaluate the Remission Rate According to Dose of Escitalopram (Lexapro®) in Patients With Major Depressive Disorder: a Preliminary Study
1What's a trial
4Get in touch
What's a trial
Not sure you're well informed about clinical trials? Learn more about their benefits, risks and other important details.
Enter your details like condition, age, gender and other preferences and we will show you a list of all relevant clinical trials.
Review the summary of the selected clinical trial and all the locations near you in order to see if it's of interest to you.
Get in touch
You've found an interesting trial? We'll need a bit more information about you so we can connect you to the doctor in charge.
Some people want to consult their doctor before considering participation in a clinical trial. This is absolutely normal as your doctor should know your medical history and should be able to advise you. If you want you can easily share the information for this trial with your doctor by clicking on the button below.